Frederic Legros is the founder of ARTHEx Biotech. ARTHEx Biotech has raised $87M in total funding. Latest round: Series B. Based in Valencia, Spain.
Frederic Legros is the Executive Chairman of the Board at ARTHEx Biotech, a clinical-stage biotechnology company located in Valencia, Spain. The company focuses on developing targeted RNA medicines for rare genetic neuromuscular disorders, including their lead program ATX-01 for Myotonic Dystrophy Type 1. ARTHEx Biotech recently upsized its Series B financing round to $87 million.
Full founder directory · Investor directory · Company funding database · Fundraising library